Role of a Pediatric Cardiologist in the COVID-19 Pandemic

Pediatr Cardiol. 2021 Jan;42(1):19-35. doi: 10.1007/s00246-020-02476-y. Epub 2020 Oct 4.

Abstract

Coronavirus disease 2019 (COVID-19) has affected patients across all age groups, with a wide range of illness severity from asymptomatic carriers to severe multi-organ dysfunction and death. Although early reports have shown that younger age groups experience less severe disease than older adults, our understanding of this phenomenon is in continuous evolution. Recently, a severe multisystem inflammatory syndrome in children (MIS-C), with active or recent COVID-19 infection, has been increasingly reported. Children with MIS-C may demonstrate signs and symptoms of Kawasaki disease, but also have some distinct differences. These children have more frequent and severe gastrointestinal symptoms and are more likely to present with a shock-like presentation. Moreover, they often present with cardiovascular involvement including myocardial dysfunction, valvulitis, and coronary artery dilation or aneurysms. Here, we present a review of the literature and summary of our current understanding of cardiovascular involvement in children with COVID-19 or MIS-C and identifying the role of a pediatric cardiologist in caring for these patients.

Keywords: COVID-19; Cardiovascular; MIS-C; Pediatric.

Publication types

  • Review

MeSH terms

  • Aged
  • COVID-19 / diagnosis
  • COVID-19 / therapy*
  • Cardiologists*
  • Child
  • Female
  • Humans
  • Male
  • Medicine
  • Mucocutaneous Lymph Node Syndrome / diagnosis
  • Mucocutaneous Lymph Node Syndrome / physiopathology
  • Pandemics*
  • Pediatrics*
  • Physician's Role*
  • SARS-CoV-2 / pathogenicity
  • Severity of Illness Index
  • Systemic Inflammatory Response Syndrome / diagnosis
  • Systemic Inflammatory Response Syndrome / therapy*

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related